banner
    APNHF image

    Aspen Pharmacare Holdings Limited

    APNHF

    12.245

    USD
    +0.01
    (+0.04%)
    Day's range
    12
    12.245
    52 wk Range
    9.205
    12.245

    Key Statistics

    Previous Close
    12.24
    Open
    12
    Day's Range
    12 - 12.245
    52 wk Range
    9.205 - 12.245
    Volume
    100
    Average Volume
    47.26563
    Market Cap
    5.44B
    Shares Outstanding
    444.23M
    Revenue
    44.71B
    Net Income
    4.40B
    EPS
    0.61
    P/E Value
    20.07
    Next Earnings Date
    Sep 01, 2025
    Dividend (Yield)
    3.02%
    Return on Assets
    3.16%
    Return on Equity
    5.17%
    Gross Profit Margin
    43.43%
    Price/Book
    0.62
    EBITDA
    9.91B
    EV/EBITDA (TTM)
    7.46
    P/BV Value
    0.62
    P/S Value
    1.18
    Beta
    0.578

    Aspen Pharmacare Holdings Limited Company Profile

    Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.

    Industry
    Drug Manufacturers - Specialty & Generic
    Sector
    Healthcare
    Employes
    8867
    Market
    ZA